Last reviewed · How we verify

Synthetic Vitamin B1 — Competitive Intelligence Brief

Synthetic Vitamin B1 (Synthetic Vitamin B1) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B1 (thiamine) supplement. Area: Nutritional/Metabolic; Neurology.

marketed Vitamin B1 (thiamine) supplement Thiamine pyrophosphokinase (enzyme target for activation); functions as cofactor for multiple metabolic enzymes Nutritional/Metabolic; Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Synthetic Vitamin B1 (Synthetic Vitamin B1) — ClinAmygate. Synthetic Vitamin B1 (thiamine) acts as a coenzyme in carbohydrate metabolism and nervous system function.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Synthetic Vitamin B1 TARGET Synthetic Vitamin B1 ClinAmygate marketed Vitamin B1 (thiamine) supplement Thiamine pyrophosphokinase (enzyme target for activation); functions as cofactor for multiple metabolic enzymes

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B1 (thiamine) supplement class)

  1. ClinAmygate · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Synthetic Vitamin B1 — Competitive Intelligence Brief. https://druglandscape.com/ci/synthetic-vitamin-b1. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: